People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotechnology, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TELA Bio, Inc. | — | Biotechnology | Series C | $104.8M | $435.1M | 2012 |
| Cerapedics Inc | — | Biotechnology | Series B | $99.1M | $492.3M | 2015 |
| Onkos Surgical, Inc. | — | Medical Devices | Series B | $72.3M | $595.7M | 2015 |
Antony Koblish at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Antony Koblish on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adele Oliva | 2 | 9 |
| Paul Touhey | 2 | 3 |
| Stephen Bloch | 1 | 15 |
| Christopher Smith | 1 | 15 |
| Jonathan Silverstein | 1 | 10 |
| Chau Khuong | 1 | 9 |
| Kevin Rakin | 1 | 7 |
| Noah Kroloff | 1 | 6 |
| Tyrell Rivers | 1 | 6 |
| Adele C. Oliva | 1 | 5 |
| Matt Zuga | 1 | 4 |
| Chen Schor | 1 | 4 |
| Vince Burgess | 1 | 3 |
| Kurt Azarbarzin | 1 | 3 |
| Glen Kashuba | 1 | 3 |
| Ashley Friedman | 1 | 2 |
| Ken Abramowitz | 1 | 2 |
| Samuel S. Wu | 1 | 1 |
| Chau J. Khuong | 1 | 1 |
| Paul J. Mraz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.